Ischemia Modified Albumin levels in patients with Stable Angina Pectoris who underwent Percutaneous Coronary Intervention
Background. Ischemia Modified Albumin (IMA) is a biomarker of myocardial ischemia. Blood levels of IMA rise in patients who develop ischemia during percutaneous coronary intervention (PCI). This study evaluated the relation between IMA levels and variables of procedure during coronary angioplasty su...
Main Authors: | Hariadi Hariawan, Otte J Rachman, Yoga Yuniadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Heart Association
2007-01-01
|
Series: | Majalah Kardiologi Indonesia |
Subjects: | |
Online Access: | http://ijconline.id/index.php/ijc/article/view/264 |
Similar Items
-
Predictors of Failure of Percutaneous Coronary Intervention in Patients with Chronic Total Coronary Occlusion at National Cardiovascular Center Indonesia
by: I Gumiwang, et al.
Published: (2007-01-01) -
Complications and Associated Risk Factors of Percutaneous Coronary Intervention: A Comparative Study Between Primary and Elective Patients
by: Ghulam Hussain Soomro, et al.
Published: (2022-04-01) -
Complications and Associated Risk Factors of Percutaneous Coronary Intervention: A Comparative Study Between Primary and Elective Patients
by: Ghulam Hussain Soomro, et al.
Published: (2022-04-01) -
Stroke in percutaneous coronary intervention – Atherothrombosis that licked heart but bit brain
by: Sandheep George Villoth, et al.
Published: (2018-12-01) -
The Role of Ischemia-modified Albumin and Ischemia-modified Albumin to Albumin Ratios in Patients with Alopecia Areata
by: Efsun TanaCan, et al.
Published: (2023-01-01)